Original Research
Published on 31 Jan 2020
Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC
in Cancer Immunity and Immunotherapy

- 8,973 views
- 40 citations
Original Research
Published on 31 Jan 2020
in Cancer Immunity and Immunotherapy

Review
Published on 31 Jan 2020
in Inflammation

Review
Published on 31 Jan 2020
in Alloimmunity and Transplantation

Review
Published on 31 Jan 2020
in Microbial Immunology

Review
Published on 31 Jan 2020
in Inflammation

Original Research
Published on 31 Jan 2020
in Multiple Sclerosis and Neuroimmunology

Original Research
Published on 31 Jan 2020
in NK and Innate Lymphoid Cell Biology

Review
Published on 31 Jan 2020
in Inflammation

Original Research
Published on 31 Jan 2020
in Comparative Immunology

Editorial
Published on 31 Jan 2020
in Molecular Innate Immunity
Editorial
Published on 31 Jan 2020
in Viral Immunology
Original Research
Published on 31 Jan 2020
in Primary Immunodeficiencies

Mini Review
Published on 30 Jan 2020
in Primary Immunodeficiencies

Original Research
Published on 30 Jan 2020
in Nutritional Immunology

Review
Published on 30 Jan 2020
in Inflammation

Original Research
Published on 30 Jan 2020
in Inflammation
